J. J. Finkelstein
Net Worth

Last updated:

What is J. J. Finkelstein net worth?

The estimated net worth of Mr. J. J. Finkelstein is at least $1,585,120 as of 30 Jun 2021. He owns shares worth $900 as insider and has received compensation worth at least $1,584,220 in RegeneRx Biopharmaceuticals, Inc..

What is the salary of J. J. Finkelstein?

Mr. J. J. Finkelstein salary is $83,380 per year as Pres, Chief Executive Officer & Director in RegeneRx Biopharmaceuticals, Inc..

How old is J. J. Finkelstein?

Mr. J. J. Finkelstein is 73 years old, born in 1952.

What stocks does J. J. Finkelstein currently own?

As insider, Mr. J. J. Finkelstein owns shares in one company:

Company Title Shares Price per share Total value
RegeneRx Biopharmaceuticals, Inc. (RGRX) Pres, Chief Executive Officer & Director 56,250 $0.02 $900

What does RegeneRx Biopharmaceuticals, Inc. do?

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.

RGRX logo
RGRX
RegeneRx Biopharmaceuticals, Inc.
$0.02

J. J. Finkelstein insider trading

RegeneRx Biopharmaceuticals, Inc.

Mr. J. J. Finkelstein has made only one insider trade between 2006-2021, according to the Form 4 filled with the SEC. He purchased 75,000 units of RGRX stock worth $15,000 on 30 Jun 2021.

As of 30 Jun 2021 he still owns at least 56,250 units of RGRX stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 75,000 $0.2 $15,000
Purchase
Series A Common Stock Warrant (right to buy) 56,250 $0.36 $20,250
Purchase
Common Stock Warrant (right to buy) 20,880 $0.21 $4,385
Purchase
Common Stock Warrant (right to buy) 78,125 $0.21 $16,406
Purchase
Common Stock Warrant (right to buy) 78,125 $0.16 $12,500
Purchase
Common Stock 4,100 N/A N/A
Purchase
Common Stock 900 N/A N/A
Purchase
Common Stock 900 N/A N/A
Purchase
Common Stock 4,100 N/A N/A
Sale
Common Stock 125,000 N/A N/A

RegeneRx Biopharmaceuticals key executives

RegeneRx Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC: